Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)
F. Lemaı̂tre, Matthieu Grégoire, Caroline Monchaud, Stéphane Bouchet, Béatrice Saint–Salvi, Élisabeth Polard, Sihem Benaboud, Laurent Chouchana, Jean‐Luc Cracowski, Milou‐Daniel Drici, R. Garraffo, Romain Guilhaumou, A.‐P. Jonville‐Béra, Mathiéu Molimard, Patric Muret, Gilles Peytavin, Vincent Richard, Caroline Solas
Topics & Concepts
RitonavirMedicineDrugPharmacologyMedical prescriptionClinical pharmacologyDrug interactionProtease inhibitor (pharmacology)Intensive care medicineFamily medicineHuman immunodeficiency virus (HIV)Viral loadAntiretroviral therapyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchPharmacological Receptor Mechanisms and Effects